| ¿µ¹® | adenoma | ÇÑ±Û | »ùÁ¾ |
|---|---|---|---|
| ¼³¸í | ºÐºñ»ùÀÇ ¼¼Æ÷¿¡¼ ±â¿øÇÏ´Â ÀüÀÌ(´Ù¸¥ Á¶Á÷À¸·Î Á÷Á¢ ¶Ç´Â Ç÷¾×À̳ª ¸²ÇÁ¸¦ µû¶ó ÆìÁ®³ª°¡´Â °Í)µÇÁö ¾Ê´Â Á¾¾ç, ¶Ç´Â »óÇǼ¼Æ÷ÀÇ Á¾¾ç Áß¿¡¼ ºÐºñ»ùÀÇ ¸ð¾çÀ» ÀÌ·ç´Â ¾ç¼º(ÀüÀ̵ÇÁö ¾Ê´Â) Á¾¾ç. |
||
| ¿µ¹® | prolactin(=PRL) | ÇÑ±Û | ÇÁ·Î¶ôƾ |
|---|---|---|---|
| ¼³¸í | Á¥ÀÇ »ý¼º°ú ºÐºñ¸¦ ÀÏÀ¸Å°´Â ÇÁ·Î¶ôƾÀº Àӽоà 5ÁÖ ÈĺÎÅÍ ºÐºñ°¡ Àϱ⠽ÃÀÛÇÏ¿© ÀӽЏ»¿¡ ºÐºñ´Â ÃÖ°íµµ¿¡ ´ÞÇÑ´Ù. ÀӽŠÁß ÇÁ·Î¶ôƾºÐºñ°¡ ÇöÀúÇÏ°Ô ³ôÀºµ¥µµ Á¥ºÐºñ°¡ ÃÊ·¡µÇÁö ¾Ê´Â °ÍÀº ÀÌ ¶§ Źݿ¡¼ ´Ù·®À¸·Î ºÐºñµÇ´Â ¿¡½ºÆ®·Î°Õ°ú ÇÁ·Î°Ô½ºÅ×·ÐÀÌ Á¥ ºÐºñ¸¦ ¾ïÁ¦Çϱ⠶§¹®ÀÌ´Ù. ºÐ¸¸ ÈÄ ¿¡½ºÆ®·Î°Õ°ú ÇÁ·Î°Ô½ºÅ×·ÐÀÇ ³óµµ°¡ ÇöÀúÇÏ°Ô ÀúÇϵǸé Á¥ÀÌ ºÐºñµÈ´Ù. ±× ¿Ü ÇÁ·Î¶ôƾÀº ³²¼º¿¡ ÀÖ¾î¼´Â È²Ã¼È È£¸£¸óÀÇ ³²¼ºÈ£¸£¸ó ºÐºñ¸¦ ÀÚ±ØÇÑ´Ù. |
||
| ¿µ¹® | white blood cell(WBC), leukocyte | ÇÑ±Û | ¹éÇ÷±¸ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, ȤÀº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀÎ Çö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | mast cell | ÇÑ±Û | ºñ¸¸ ¼¼Æ÷ |
|---|---|---|---|
| ¼³¸í | µ¿¹°ÀÇ °áÇÕ Á¶Á÷ °¡¿îµ¥ ³Î¸® ºÐÆ÷ÇÏ´Â ¼¼Æ÷. °áÇÕÁ¶Á÷°ú Á¡¸·Á¶Á÷ ³»¿¡ Àִ ȣ¿°±â¼º »ö¼Ò·Î ÀÌ¿°»ö¼º(metachromasia)À» ³ªÅ¸³»´Â °ú¸³À» °¡Áø ¹æÃßÇüÀÇ ¼¼Æ÷¿¡ ÀÛÀº µÕ±Ù ÇÙÀ» °¡Áø´Ù. ºñ¸¸¼¼Æ÷ÀÇ Ç¥¸é¿¡´Â IgE¿¡ ´ëÇÑ ¼ö¿ëü°¡ Á¸ÀçÇϸç, ¼ö¿ëü¿¡ °áÇÕÇÑ IgE ºÐÀڵ鳢¸® ´Ù°¡ÀÇ Ç׿ø¿¡ ÀÇÇØ ¼·Î ¿¬°áµÇ¸é ºñ¸¸¼¼Æ÷ °ú¸³Å»Ãâ ¹ÝÀÀÀÌ ÀϾ, È÷½ºÅ¸¹Î, ¼¼·ÎÅä´Ñ, ÇìÆÄ¸° µîÀÇ ÈÇÐÀü´Þ ¹°ÁúÀÌ ¹æÃâµÇ¾î, Áï½ÃÇü ¾Ë·¹¸£±â ¹ÝÀÀ µîÀÇ Áõ»óÀ» ÀÏÀ¸Å²´Ù. ÇǺÎ, À帷, Ç÷°ü ÁÖÀ§, Á¡¸· ÁÖº¯¿¡ ÀÖ´Ù. |
||
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
|---|---|
| PIF | paratoid isoelectric focusing variant protein; peak inspiratory flow; proinsulin-free; prolactin-inh... |
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
| HCA | heart cell aggregate; hepatocellular adenoma; home care aide; Hospital Corporation of America; hydro... |
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| APA | Aldosterone Producing Adenoma |
|---|---|
| dra | Down Regulated in Adenoma |
| HA | Hepatic Adenoma |
| PA | Pleomorphic Adenoma |
| TA | Toxic adenoma |
| prolactin-producing adenoma | <tumour> A pituitary adenoma composed of prolactin-producing cells; it gives rise to symptoms of nonpuerperal amenorrhoea and galactorrhoea (Forbes-Albright syndrome) in women and to impotence in men. Synonym: prolactinoma. (05 Mar 2000) |
|---|---|
| prolactin cell | An acidophilic cell of the adenohypophysis that produces prolactin. Synonym: prolactin cell. (05 Mar 2000) |
| receptors, prolactin | Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor. (12 Dec 1998) |
| chorionic growth hormone-prolactin | human placental lactogen |
| prolactin | <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion. (18 Nov 1997) |
| prolactin-inhibiting factor | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
| prolactin-inhibiting hormone | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
| prolactin protease | <enzyme> From pituitary lysosomes of lactating rats Registry number: EC 3.4.99.- (26 Jun 1999) |
| prolactin release-inhibiting hormone | <chemical> A polypeptide hormone produced in the hypothalamus that inhibits the release of prolactin. Chemical name: Prolactin release-inhibiting factor (12 Dec 1998) |
| prolactin-releasing factor | A substance of hypothalamic origin that stimulates the release of prolactin. Synonym: prolactin-releasing factor, prolactin-releasing hormone. Origin: prolactin + L. Libero, to free, + -in (05 Mar 2000) |
| prolactin-releasing hormone | A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. (12 Dec 1998) |
| prolactin unit | The specific lactogenic activity contained in 0.1 mg of the standard preparation of the lactogenic substance of the anterior pituitary gland. (05 Mar 2000) |
| adenoma, islet cell | A benign tumour of the islets of langerhans that may occur anywhere throughout the pancreas. Such tumours may result in hyperinsulinism or zollinger-ellison syndrome. (12 Dec 1998) |
| adenoma, liver cell | A benign epithelial tumour of the liver. (12 Dec 1998) |
| basal cell adenoma | <tumour> A benign tumour of major or minor salivary glands or other organs composed of small cells showing peripheral palisading. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|